USPTO serial 97878353
N POWER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WUDARSKY, MINDY CHEK
- Law office
- TMO LAW OFFICE 117
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with N POWER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rachel Huffstetler
Rachel Huffstetler Pierson Ferdinand LLP4279 Roswell Rd.Ste 208, No. 260Atlanta, GA 30342Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for computers and handheld computers, namely, downloadable data tracking and communication software; downloadable medical research industry clinical trial software for clinical trial management and cohort selection and identification; downloadable data analytics and reporting software; downloadable clinical data collection software; downloadable clinical trial management software, namely, downloadable software for identifying and selecting patients for inclusion in trial cohorts and management of trial participation; downloadable clinical trial patient monitoring software; downloadable data integration and transmission software; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information for use in clinical trials; downloadable software for the collection, editing, organizing, modifying, book marking, transmission, storage, sharing of data information, patient reported outcomes and clinical outcomes and assessments, on computing devices; downloadable software for the capture, reporting, and processing of data in clinical trials; downloadable software for enabling the capture, reporting, and processing of clinical outcomes assessments in clinical trials; downloadable computer software for use in connection with data networks for providing information for patients and doctors to identify clinical trials; downloadable computer software for use in database management and support for use in data collection in connection with clinical trials; downloadable computer software using artificial intelligence for clinical trial management and cohort selection and identification in the field of healthcare; downloadable computer programs using artificial intelligence for machine learning in the field of healthcare; downloadable computer software using artificial intelligence for machine learning used in computer healthcare programs; downloadable computer software using artificial intelligence for clinical trial management and cohort selection and identification; downloadable computer software using artificial intelligence for analysis of clinical trial data; data processing apparatus incorporating recorded computer software using artificial intelligence; downloadable interactive computer software using artificial intelligence for clinical trial management and cohort selection and identification; recorded computer software using artificial intelligence for machine learning; downloadable computer programs using artificial intelligence for machine learning using natural language processing; downloadable computer programs using artificial intelligence and natural language processing for managing clinical trials and managing cohort selection and identification for clinical trials; downloadable computer software using natural language processing for the capture, reporting, and processing of data in clinical trials; downloadable computer programs using artificial intelligence for managing clinical trials and managing cohort selection and identification for clinical trials; in the field of medical scribing services; all of the foregoing in the field of clinical trials | ACTIVE | — |
| 035 | Business services provided to the healthcare industry in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business services provided to the healthcare industry in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare data for business purposes; electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; maintaining a registry of databases in the field of healthcare; maintaining a registry of databases for purposes of tracking healthcare data; maintaining a registry of databases for purposes of health information and health histories; maintaining a registry of databases for purposes of clinical research; maintaining a registry of databases for purposes of identifying patients eligible for clinical trials; medical scribing services; business services provided to the healthcare industry, namely, medical coding services for others in the nature of assignment of diagnostic and procedural codes for data analysis; all of the foregoing in the field of clinical trials; data administration on servers, namely, data processing services, relating to clinical trials data | ACTIVE | — |
| 042 | Medical research and development ; providing medical and scientific research information in the fields of oncology and clinical trials; software as a service (SAAS) services featuring software for matching cancer patients with appropriate therapeutic options and clinical trials; software as a service (SaaS) services featuring software for identification of clinical trials, namely, for identifying and recruiting patients for participation in clinical trials, and matching patients with clinical trials; software as a service (SaaS) services featuring software for collecting, managing, and analyzing healthcare data, biologic data, medical device data, and clinical trial data; providing information in the nature of healthcare data, biologic data, medical device data, clinical trial data, and patient data, and analysis of such data, all for clinical research and development; consulting services in the field of design, planning, and implementation of clinical trials; providing temporary use of online non-downloadable software and mobile applications for use in data tracking and communication; providing temporary use of online non-downloadable software and mobile applications for use in database management and support for use in data collection in connection with clinical trials; medical and scientific research, data collection and data analysis in the nature of performing clinical research and conducting clinical trials for others in the fields of health care, medical care and pharmaceutical use; provision of an internet-based database for data entry and management in the field of clinical trials; provision of online non-downloadable computer software platforms on the internet for clinical trial management and cohort selection and identification; in the field of clinical trials; design and development of computer software relating to the field of clinical trials; maintenance and updating of computer software relating to the field of clinical trials; provision of a website for internet storage space, namely, for electronic storage of data relating to clinical trials; providing a website featuring technology that enables the sharing of information related to oncology clinical trial; computer services, namely, provision of online non-downloadable software featuring search functions to enable users to identify clinical trials; software as a service (SAAS) services featuring software for capturing medical data from patients for the purpose of remote patient monitoring and care coordination; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient reported outcomes on computing devices; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient reported outcomes on computing devices including handhelds, PDAs, web based, short message service, and mobile devices; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of clinician and observer reported outcomes on web based, short message service, and mobile devices; software as a service (SAAS) services featuring software for interfacing and integrating with third party clinical systems to enable transferring, collecting, viewing, and sharing of clinical study data; providing an online computer database in the field of clinical trials for purposes of tracking healthcare data in the nature of clinical trial data; providing an online computer database for purposes of clinical research; providing an online computer database for purposes of identifying patients eligible for clinical trials; software as a service featuring software for machine learning; software as a service featuring artificial intelligence technology; software as a service (SAAS) services featuring software using artificial intelligence for machine learning and natural language processing; software as a service (SAAS) services featuring software using artificial intelligence using natural language processing for clinical trial management and cohort selection and identification; software as a service (SAAS) services featuring software using natural language processing for the capture, reporting, and processing of data in clinical trials; providing online non-downloadable computer software development tools using artificial intelligence for clinical trial management and cohort selection and identification; in the field of artificial intelligence; providing online non-downloadable computer software using artificial intelligence for medical transcription; all of the foregoing in the field of clinical trials | ACTIVE | — |
| 044 | providing an online computer database in the field of healthcare, namely, oncology; providing an online computer database in the field of healthcare for purposes of tracking healthcare data in the nature of patient data; providing an online computer database in the field of healthcare featuring health information and health histories; health care services, namely, providing a health information database in the field of the oncology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by n-Power Medicine, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named N POWER
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 3, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 3, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 26, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 26, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 26, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 25, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 25, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 25, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 21, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 21, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 21, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 16, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 16, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 16, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 2, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2023 | NWAP | NEW APPLICATION ENTERED | — |